Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
4.770
+0.590 (14.11%)
Oct 23, 2025, 3:55 PM EDT - Market open
Turn Therapeutics Statistics
Total Valuation
TTRX has a market cap or net worth of $133.67 million. The enterprise value is $112.93 million.
Market Cap | 133.67M |
Enterprise Value | 112.93M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
TTRX has 28.02 million shares outstanding. The number of shares has increased by 2.66% in one year.
Current Share Class | 28.02M |
Shares Outstanding | 28.02M |
Shares Change (YoY) | +2.66% |
Shares Change (QoQ) | +1.04% |
Owned by Insiders (%) | 62.27% |
Owned by Institutions (%) | n/a |
Float | 9.14M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 66.01 |
P/TBV Ratio | 122.67 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.06.
Current Ratio | 3.20 |
Quick Ratio | 3.01 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -341.26% and return on invested capital (ROIC) is -213.85%.
Return on Equity (ROE) | -341.26% |
Return on Assets (ROA) | -58.09% |
Return on Invested Capital (ROIC) | -213.85% |
Return on Capital Employed (ROCE) | -84.19% |
Revenue Per Employee | n/a |
Profits Per Employee | -$639,638 |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 1,952,388 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.75M |
Pretax Income | -2.56M |
Net Income | -2.56M |
EBITDA | -2.70M |
EBIT | -2.75M |
Earnings Per Share (EPS) | -$0.09 |
Balance Sheet
The company has $3.19 million in cash and $101,446 in debt, giving a net cash position of $3.09 million or $0.11 per share.
Cash & Cash Equivalents | 3.19M |
Total Debt | 101,446 |
Net Cash | 3.09M |
Net Cash Per Share | $0.11 |
Equity (Book Value) | 1.77M |
Book Value Per Share | 0.06 |
Working Capital | 2.33M |
Cash Flow
Operating Cash Flow | -1.60M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TTRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.66% |
Shareholder Yield | -2.66% |
Earnings Yield | -2.21% |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |